Hyflux has agreed to sell a 60 per cent stake for SGD 400 million ($290 million) to a consortium of Indonesia’s Salim Group and Medco Group.
The consortium, SM Investments, will lend a further SGD 130 million ($94 million) to the embattled Hyflux.
Salim Group is Indonesia’s largest conglomerate, with business interests from food and beverage to oil palm plantations to property development. Medco Group, also an Indonesian conglomerate, operates in sectors from agriculture to energy to hotels to manufacturing.
“We see tremendous potential for synergies between Hyflux and our existing businesses, as well as opportunities in our consortium that can involve Hyflux. We will work with Hyflux to keep its flagship assets intact, bearing in mind the significance of this company to Singapore,” said Salim Group chairman Anthony Salim.
Sembcorp’s solitary offer for Tuaspring falls short of book value (October 2018)
Hyflux applies to High Court for moratorium on action against subsidiaries (May 2018)